- 8/26/22, Jacquelyn M. Evans, Cornell University
- 9/2/22, Yuanquan Song, Children’s Hospital of Philadelphia Research Institute
- 9/13/22, Alwin Hohler, University of Vienna
- 9/23/22, Tin Tin Su, University of Colorado
- 9/30/22, Brian D. Rudd and Praveen Sethupathy, Immunogenics Symposium, Cornell University
- 10/07/22, Distinguished Seminar Series in Genome Biology by Dr. Molly Hammell, Cold Springs Harbor Laboratory
- 10/14/22, Life Science Lecture by Dr. Laura Landweber, Columbia University
- 10/21/22, Yong Xiong, Yale University
- 10/28/22, David Schneider , Stanford University
SeminarThree Molecular Subtypes of ALS: Stress, Inflammation and Transposons
Researchers have uncovered a novel pathway that explains how cancer cells become resistant to chemotherapies, which in turn offers a potential solution for preventing chemo-resistance.
New research from Cornell offers insights into a line of CRISPR systems, which could lead to promising antiviral and tissue engineering tools in animal and plants.